ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Brain Stem Neoplasms

  • Anlotinib to Malignant Brainstem Glioma
  • A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
  • Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
  • Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
  • Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
  • Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
  • p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
  • Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
  • A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
  • Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group